Alternative therapies for choroidal neovessels resulting from age-related macular degeneration;Thérapeutiques alternatives des néovaisseaux choroïdiens de la dégénérescence maculaire liée à l'âge

Journal Francais d'Ophtalmologie

Volumn 26, Issue 8, 2003, Pages 876-878

  Soubrane, G ^a   Souied, E ^a   Haddad, W ^a   Razavi, S ^a   Roquet, W ^a   Coscas, G ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Age related macular degeneration; Antiangiogenesis; Antioxidant supplementation; Choroidal neovessels; Transpupillary thermotherapy

Indexed keywords

ALPHA TOCOPHEROL; ALPHA2A INTERFERON; ANECORTAVE; ANGIOGENESIS INHIBITOR; ANTIOXIDANT; APTAMER; ASCORBIC ACID; OLIGONUCLEOTIDE; RETINOL; STEROID; THALIDOMIDE; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY; ZINC;

ARTICLE; CENTRAL SCOTOMA; CLINICAL TRIAL; DISEASE MODEL; EVALUATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERTHERMIC THERAPY; IATROGENIC DISEASE; LASER COAGULATION; NONHUMAN; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PILOT STUDY; RANDOMIZATION; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION; TRANSPUPILLARY THERMOTHERAPY; VITAMIN SUPPLEMENTATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; FOVEA CENTRALIS; HUMANS; HYPERTHERMIA, INDUCED; MACULAR DEGENERATION; MULTICENTER STUDIES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PORPHYRINS; PREGNADIENEDIOLS; PUPIL; RANDOMIZED CONTROLLED TRIALS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; ZINC;

EID: 0242268117     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Arch Ophthalmol, 1986;104:694-701.
2. Coscas G, Soubrane G. Photocoagulation des néovaisseaux sous-rétiniens dans la dégénérescence maculaire sénile par laser à argon. Résultats de l'étude randomisée de 60 cas. Bull Mem Soc Fr Ophtalmol, 1983;94:149-54.
3. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol, 2001;119:198-207.
4. Verteporfine In Photodynamic therapy (VIP) Study Group. PDT of subfoveal occult choroidal neovascularization in age-related macular degeneration with verteporfin: VIP Report 2. Arch Ophthalmol, 2001;119:198-207.
5. Flower RW, Von Kerczek C, Zhu L, Ernest A, Eggleton C, Topoleski LD. Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. Am J Ophthalmol, 2001;132:85-93.
6. Staurenghi G, Orzalesi N, La Capria A, Ashero M. Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes. A revisitation using dynamic indocyanine green angiography. Ophthalmology, 1998;105:2297-2305.
7. The Choroidal Neovascularization Prevention Trial Research Group. Choroidal neovascularization in the choroidal neovascularization prevention trial. Ophthalmology, 1998;105:1364-72.
8. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol, 1999;237:313-25.
9. De Juan E Jr, Fujii GY. Limited macular translocation. Eye, 2001;15:413-23.
10. Reichel E, Berrocal AM, Ip M, Kroll AJ, Desai V, Duker JS et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology, 1999;106:1908-14.
11. Thompson JT. Retinal pigment epithelial tear after transpupillary thermotherapy for choroidal neovascularization. Am J Ophthalmol, 2001;131:662-4.
12. Lanzetta P, Michieletto P, Pirracchio A, Bandello F. Early vascular changes induced by transpupillary thermotherapy of choroidal neovascularization. Ophthalmology, 2002;109:1098-104.
13. Pharmacological Therapy for Macular Degeneration Study Group. Interferon alfa 2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical tria. Arch Ophthalmol, 1997;115:865-72.
14. Clark AF, Mellon J, Li XY, Ma D, Leher H, Apte R et al. Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci, 1999;40:2158-62.
15. The Eyetech Study GroupPreclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (eye001) for the treatment of exudative age-related macular degeneration. Retina, 2002;22:143-52.
16. AREDS. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss. AREDS report n° 9. Arch Ophthalmol, 2001;119:1439-52.